Free Trial

NeuroSense Therapeutics (NRSN) Short Interest Ratio & Short Volume

NeuroSense Therapeutics logo
$1.27
+0.02 (+1.60%)
(As of 11/1/2024 ET)

NeuroSense Therapeutics Short Interest Data

NeuroSense Therapeutics (NRSN) has a short interest of 235,700 shares, representing 1.62% of the float (the number of shares available for trading by the public). This marks a -23.32% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.9, indicating that it would take 0.9 days of the average trading volume of 266,598 shares to cover all short positions.

Current Short Interest
235,700 shares
Previous Short Interest
307,400 shares
Change Vs. Previous Month
-23.32%
Dollar Volume Sold Short
$225,564.90
Short Interest Ratio
0.9 Days to Cover
Last Record Date
October 15, 2024
Outstanding Shares
13,670,000 shares
Float Size
14,550,000 shares
Short Percent of Float
1.62%
Today's Trading Volume
492,412 shares
Average Trading Volume
266,598 shares
Today's Volume Vs. Average
185%
Short Selling NeuroSense Therapeutics?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for NeuroSense Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

NRSN Short Interest Over Time

NRSN Days to Cover Over Time

NRSN Percentage of Float Shorted Over Time

NeuroSense Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
10/15/2024235,700 shares $225,564.90 -23.3%1.6%0.9 $0.96
9/30/2024307,400 shares $390,398.00 -20.3%2.1%1 $1.27
9/15/2024385,600 shares $520,560.00 -18.1%2.7%1 $1.35
8/31/2024470,700 shares $418,923.00 +236.2%3.3%1.2 $0.89
8/15/2024140,000 shares $103,600.00 +73.7%1.0%0.5 $0.74
7/31/202480,600 shares $61,239.88 -44.8%0.6%0.3 $0.76
7/15/2024146,000 shares $134,918.60 +715.6%1.1%0.6 $0.92
6/30/202417,900 shares $20,048.00 +121.0%0.1%0.1 $1.12
6/15/20248,100 shares $7,857.00 -17.4%0.1%0.1 $0.97
5/31/20249,800 shares $10,584.00 -52.4%0.1%0.1 $1.08
5/15/202420,600 shares $24,678.80 +13.2%0.2%0.1 $1.20
4/30/202418,200 shares $24,570.00 -79.4%0.2%0.1 $1.35
4/15/202488,400 shares $135,252.00 +38.8%0.8%0.3 $1.53
3/31/202463,700 shares $115,934.00 +81.5%0.7%0.2 $1.82
3/15/202435,100 shares $48,438.00 -83.4%0.4%0.1 $1.38
2/29/2024211,400 shares $374,178.00 +42.0%2.3%0.5 $1.77
2/15/2024148,900 shares $198,037.00 +12.7%1.6%0.2 $1.33
1/31/2024132,100 shares $165,125.00 -35.6%1.5%0.2 $1.25
1/15/2024205,200 shares $175,261.32 -17.7%2.3%0.2 $0.85
12/31/2023249,200 shares $195,622.00 +18.7%2.7%0.3 $0.79
12/15/2023210,000 shares $176,631.00 +1.9%2.3%0.2 $0.84
11/30/2023206,100 shares $265,869.00 -11.9%2.3%0.3 $1.29
11/15/2023234,000 shares $120,276.00 +89.3%2.6%1 $0.51
10/31/2023123,600 shares $56,930.16 +182.2%1.4%0.6 $0.46
10/15/202343,800 shares $23,956.67 +91.3%0.5%0.3 $0.55
9/30/202322,900 shares $16,259.00 -3.8%0.3%0.3 $0.71
9/15/202323,800 shares $20,944.00 +9.2%0.3%0.6 $0.88
8/31/202321,800 shares $20,492.00 +77.2%0.2%0.5 $0.94
8/15/202312,300 shares $11,808.00 -37.6%0.1%0.2 $0.96
7/31/202319,700 shares $25,610.00 -53.4%0.3%0.3 $1.30
7/15/202342,300 shares $57,528.00 -38.3%0.6%0.5 $1.36
6/30/202368,600 shares $102,214.00 -12.4%1.0%0.9 $1.49
6/15/202378,300 shares $144,072.00 -38.8%1.2%1 $1.84
5/31/2023127,900 shares $199,524.00 -13.6%1.9%1.9 $1.56
5/15/2023148,000 shares $253,080.00 -1.7%2.2%2.9 $1.71
4/30/2023150,600 shares $304,212.00 -12.0%2.2%2 $2.02
4/15/2023171,100 shares $278,893.00 -8.2%2.5%1.4 $1.63
3/31/2023186,300 shares $320,436.00 -6.1%2.8%0.1 $1.72
3/15/2023198,300 shares $354,957.00 -6.4%3.1%0.1 $1.79
2/28/2023211,800 shares $393,948.00 -10.1%3.1%0.2 $1.86
Elon knows the truth, which is why they want him silenced (Ad)

Elon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to humanity, there is a war being waged on Elon Musk. This war has nothing to do with X, Elon’s stance on immigration or his support for Donald Trump.

Watch this new documentary and you’ll discover what Elon knows,
2/15/2023235,700 shares $393,619.00 +8.2%3.4%0.2 $1.67
1/31/2023217,900 shares $337,745.00 +1,479.0%3.2%0.2 $1.55
1/15/202313,800 shares $18,630.00 -25.0%0.2%0 $1.35
12/30/202218,400 shares $22,448.00 -24.6%0.3%0.7 $1.22
12/15/202224,400 shares $37,332.00 -22.0%0.4%0.8 $1.53
11/30/202231,300 shares $53,836.00 +30.4%0.5%0.9 $1.72
11/15/202224,000 shares $40,800.00 -21.8%0.4%0.6 $1.70
10/31/202230,700 shares $49,120.00 -40.0%0.5%0.8 $1.60
10/15/202251,200 shares $87,552.00 -53.7%0.7%0.7 $1.71
9/30/2022110,500 shares $197,795.00 +269.6%1.6%1.1 $1.79
9/15/202229,900 shares $61,893.00 +13.7%0.4%0 $2.07
8/31/202226,300 shares $51,285.00 -46.8%0.4%0 $1.95
8/15/202249,400 shares $111,150.00 +31.4%0.8%0 $2.25
7/31/202237,600 shares $70,312.00 -36.5%0.6%0 $1.87
7/15/202259,200 shares $121,952.00 -91.8%0.9%0 $2.06
6/30/2022719,900 shares $2.43 million +302.4%11.7%0.2 $3.38
6/15/2022178,900 shares $305,919.00 +1.6%2.9%0.2 $1.71
5/31/2022176,100 shares $248,301.00 +78.8%2.9%0 $1.41
5/15/202298,500 shares $125,095.00 +64.2%1.6%0 $1.27
4/30/202260,000 shares $100,800.00 +26.3%1.0%0 $1.68
4/15/202247,500 shares $95,950.00 -86.3%N/A0 $2.02
3/31/2022347,000 shares $1.38 million +568.6%5.7%0.1 $3.97
3/15/202251,900 shares $72,660.00 +464.1%0.9%0 $1.40
2/28/20229,200 shares $23,920.00 +187.5%0.2%0 $2.60
2/15/20223,200 shares $5,568.00 -38.5%0.1%0 $1.74
1/31/20225,200 shares $10,244.00 -80.4%0.1%0 $1.97
1/15/202226,500 shares $72,875.00 +69.9%0.4%0.1 $2.75
12/31/202115,600 shares $38,376.00 No Change0.3%0 $2.46

NRSN Short Interest - Frequently Asked Questions

What is NeuroSense Therapeutics' current short interest?

Short interest is the volume of NeuroSense Therapeutics shares that have been sold short but have not yet been closed out or covered. As of October 15th, investors have sold 235,700 shares of NRSN short. 1.62% of NeuroSense Therapeutics' shares are currently sold short. Learn More on NeuroSense Therapeutics' current short interest.

What is a good short interest ratio for NeuroSense Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. NRSN shares currently have a short interest ratio of 1.0. Learn More on NeuroSense Therapeutics's short interest ratio.

What is a good short interest percentage for NeuroSense Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.62% of NeuroSense Therapeutics' floating shares are currently sold short.

Is NeuroSense Therapeutics' short interest increasing or decreasing?

NeuroSense Therapeutics saw a decrease in short interest during the month of October. As of October 15th, there was short interest totaling 235,700 shares, a decrease of 23.3% from the previous total of 307,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is NeuroSense Therapeutics' float size?

NeuroSense Therapeutics currently has issued a total of 13,670,000 shares. Some of NeuroSense Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. NeuroSense Therapeutics currently has a public float of 14,550,000 shares.

How does NeuroSense Therapeutics' short interest compare to its competitors?

1.62% of NeuroSense Therapeutics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to NeuroSense Therapeutics: ALX Oncology Holdings Inc. (31.74%), Verrica Pharmaceuticals Inc. (17.38%), Spero Therapeutics, Inc. (0.72%), Citius Pharmaceuticals, Inc. (6.87%), RAPT Therapeutics, Inc. (8.22%), Onconetix, Inc. (0.31%), Syros Pharmaceuticals, Inc. (4.82%), Eupraxia Pharmaceuticals Inc. (0.39%), Connect Biopharma Holdings Limited (0.09%), Gain Therapeutics, Inc. (2.36%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.14 billion), AppLovin Co. ($3.15 billion), Paychex, Inc. ($2.69 billion), Nu Holdings Ltd. ($2.48 billion), Cencora, Inc. ($2.24 billion), International Paper ($2.04 billion), Tractor Supply ($1.96 billion), Coinbase Global, Inc. ($1.93 billion), Moderna, Inc. ($1.91 billion), and SoFi Technologies, Inc. ($1.84 billion). View all of the most shorted stocks.

What does it mean to sell short NeuroSense Therapeutics stock?

Short selling NRSN is an investing strategy that aims to generate trading profit from NeuroSense Therapeutics as its price is falling. NRSN shares are trading up $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against NeuroSense Therapeutics?

A short squeeze for NeuroSense Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of NRSN, which in turn drives the price of the stock up even further.

How often is NeuroSense Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NRSN, twice per month. The most recent reporting period available is October, 15 2024.




This page (NASDAQ:NRSN) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners